These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Helicase-primase inhibitors for herpes simplex virus: looking to the future of non-nucleoside inhibitors for treating herpes virus infections. Biswas S; Sukla S; Field HJ Future Med Chem; 2014 Jan; 6(1):45-55. PubMed ID: 24358947 [TBL] [Abstract][Full Text] [Related]
25. Development of acyclovir-resistant herpes simplex virus early during the treatment of herpes neonatorum. Levin MJ; Weinberg A; Leary JJ; Sarisky RT Pediatr Infect Dis J; 2001 Nov; 20(11):1094-7. PubMed ID: 11734722 [TBL] [Abstract][Full Text] [Related]
26. Helicase-primase inhibitor amenamevir for herpesvirus infection: Towards practical application for treating herpes zoster. Shiraki K Drugs Today (Barc); 2017 Nov; 53(11):573-584. PubMed ID: 29451274 [TBL] [Abstract][Full Text] [Related]
27. Herpes simplex virus helicase-primase inhibitors: recent findings from the study of drug resistance mutations. Biswas S; Field HJ Antivir Chem Chemother; 2008; 19(1):1-6. PubMed ID: 18610552 [TBL] [Abstract][Full Text] [Related]
28. Emergence of varicella-zoster virus resistance to acyclovir: epidemiology, prevention, and treatment. Shiraki K; Takemoto M; Daikoku T Expert Rev Anti Infect Ther; 2021 Nov; 19(11):1415-1425. PubMed ID: 33853490 [No Abstract] [Full Text] [Related]
29. [Herpes simplex virus infection: an overview of the problem, pharmacologic therapy and dietary measures]. Hassan STS; Šudomová M; Masarčíková R Ceska Slov Farm; 2017; 66(3):95-102. PubMed ID: 28914066 [TBL] [Abstract][Full Text] [Related]
31. Multiple herpes simplex virus infections with various resistance patterns in a matched unrelated donor transplant recipient. Arnulf B; Chebbi F; Lefrere F; Ait Arkoub Z; Varet B; Fillet AM Bone Marrow Transplant; 2001 Oct; 28(8):799-801. PubMed ID: 11781635 [TBL] [Abstract][Full Text] [Related]
32. Novel agents and strategies to treat herpes simplex virus infections. Kleymann G Expert Opin Investig Drugs; 2003 Feb; 12(2):165-83. PubMed ID: 12556212 [TBL] [Abstract][Full Text] [Related]
33. Herpes simplex virus drug-resistance: new mutations and insights. Andrei G; Snoeck R Curr Opin Infect Dis; 2013 Dec; 26(6):551-60. PubMed ID: 24152761 [TBL] [Abstract][Full Text] [Related]
34. [Clinical utility of susceptibility testing of herpes simplex virus to acyclovir]. Otegui M; Rabella N; Labeaga R; Herrero M; Margall N; Muñoz JM; Prats G Rev Esp Quimioter; 2001 Dec; 14(4):351-7. PubMed ID: 11856981 [TBL] [Abstract][Full Text] [Related]
35. Infection due to acyclovir resistant herpes simplex virus in patients undergoing allogeneic hematopoietic stem cell transplantation. Venard V; Dauendorffer JN; Carret AS; Corsaro D; Edert D; Bordigoni P; Le Faou A Pathol Biol (Paris); 2001 Sep; 49(7):553-8. PubMed ID: 11642018 [TBL] [Abstract][Full Text] [Related]
36. Novel targets for the development of anti-herpes compounds. Greco A; Diaz JJ; Thouvenot D; Morfin F Infect Disord Drug Targets; 2007 Mar; 7(1):11-8. PubMed ID: 17346207 [TBL] [Abstract][Full Text] [Related]
37. Long-term follow-up of HIV-infected patients once diagnosed with acyclovir-resistant herpes simplex virus infection. Seang S; Boutolleau D; Burrel S; Regnier S; Epelboin L; Voujon D; Valantin MA; Katlama C; Agut H; Caumes E Int J STD AIDS; 2014 Aug; 25(9):676-82. PubMed ID: 24535691 [TBL] [Abstract][Full Text] [Related]
38. [Contribution of the laboratory in case of resistance to acyclovir of herpes simplex and varicella zoster virus]. Morfin F; Frobert E; Thouvenot D Ann Biol Clin (Paris); 2003; 61(1):33-40. PubMed ID: 12604384 [TBL] [Abstract][Full Text] [Related]
39. The helicase-primase inhibitor BAY 57-1293 reduces the Alzheimer's disease-related molecules induced by herpes simplex virus type 1. Wozniak MA; Frost AL; Itzhaki RF Antiviral Res; 2013 Sep; 99(3):401-4. PubMed ID: 23867133 [TBL] [Abstract][Full Text] [Related]
40. 2-[4,5-Difluoro-2-(2-fluorobenzoylamino)-benzoylamino]benzoic acid, an antiviral compound with activity against acyclovir-resistant isolates of herpes simplex virus types 1 and 2. Strand M; Islam K; Edlund K; Oberg CT; Allard A; Bergström T; Mei YF; Elofsson M; Wadell G Antimicrob Agents Chemother; 2012 Nov; 56(11):5735-43. PubMed ID: 22908173 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]